Tag Archives: Vaccines
Top New Science Podcasts: Covid-19 Vaccine Fears And Origin Controversies
Also this week, Sarah talks with Science Senior Correspondent Jon Cohen about his story on Chinese scientist Shi Zhengli, the bat researcher at the center of the COVID-19 origins controversy—and why she thinks President Donald Trump owes her an apology.
Finally, Geert Van der Snickt, a professor in the conservation-restoration department at the University of Antwerp, talks with Sarah about his Science Advances paper on a new process for peering into the past of paintings. His team used a combination of techniques to look beneath an overpainting on the Ghent Altarpiece by Hubert and Jan Van Eyck—a pivotal piece that showed the potential of oil paints and even included an early example of painting from an aerial view.
Morning News Podcast: New Stimulus Bill, Covid-19 Vaccine & Civil Rights
This week, lawmakers in Capitol Hill are trying to piece together the next stimulus package as many benefits like unemployment insurance and forgiving evictions expire. Democrats and Republicans both agree that a new bill is necessary but there’s been a lot of back and forth about the specifics. And they’re running out of time.
- Plus, a reality check on the coronavirus vaccine.
- And, the silver lining for civil rights this year.
Guests: Axios’ Alayna Treene, Sam Baker, and Sara Fischer.
Morning News Podcast: Race For Covid-19 Vaccine, Swing States & Fall TV
The U.K. and China made big news with promising results in vaccine development for the coronavirus — the US, Russia and at least five other countries are also working on possible vaccines.
But for a vaccine to work effectively, these countries should be working together. Instead, they’re clashing. Countries like the US and Canada have even accused Russia of stealing our vaccine research. Plus:
- Pennsylvania, Wisconsin, North Carolina and Georgia are all swing states at the center of the 2020 voting crisis.
- And, how the virus will wreak havoc on your fall TV lineup.
Guests: Axios’ Dave Lawler, Stef Kight, and Sara Fischer
Top New Science Podcasts: Megatrials For Covid-19 Treatment & Blood Benefits Of Exercise
Contributing correspondent Kai Kupferschmidt talks with host Sarah Crespi about the success of a fast moving megatrial for coronavirus treatments. The United Kingdom’s Recovery (Randomized Evaluation of COVID-19 Therapy) trial has enrolled more than 12,000 hospitalized coronavirus patients since early March and has released important recommendations that were quickly taken up by doctors and scientists around the world.
Kupferschmidt discusses why such a large study is necessary and why other large drug trials like the World Health Organization’s Solidarity trial are lagging behind. Also this week, producer Meagan Cantwell talks with Saul Villeda, a professor in the Department of Anatomy at the University of California, San Francisco, about transferring the beneficial effects of exercise on the brain from an active mouse to a sedentary mouse by transferring their blood.
Coronavirus Vaccines: The Promise And Peril In Fast-Tracking (WSJ Video)
As the coronavirus continues to spread around the globe, companies and academic labs are racing to develop a vaccine that would help society get back to normal. But there could also be costs to moving too quickly.
WSJ’s Daniela Hernandez explains. Photo illustration: Laura Kammermann
Top Science Podcasts: Latest Update On Covid-19 Vaccines, WHO Ultimatum
The first results from vaccine trials are in and they are encouraging, but scientists are still urging caution. We hear the lowdown on the types of vaccines being developed and what hope there is of rolling them out any time soon.
01:38 Trump vs the WHO
President Trump has given the WHO an ultimatum in a tweet, threatening to pull out of the organisation within 30 days unless unclear demands are met. We discuss what this means for the pandemic, the USA and the future of international health cooperation
12:06 Where are we with vaccines?
The first results from vaccine trials are in and they are encouraging, but scientists are still urging caution. We hear the lowdown on the types of vaccines being developed and what hope there is of rolling them out any time soon.
News: Coronavirus vaccine trials have delivered their first results — but their promise is still unclear
News: The race for coronavirus vaccines: a graphical guide
News: If a coronavirus vaccine arrives, can the world make enough?
25:20 One good thing
Our hosts pick out things that have made them smile in the last week, including hopeful antibody research, at-home sketch comedy and printable board games.
News: Potent human antibodies could inspire a vaccine
Video: Whiskers R we – SNL
Video:The wild affordable world of 1 Player Print’n’Play Games
Video:MORE of the Very Best Solitaire Print’n’Play Games
Video: Marble run league
Video: BBC goals at home (Only available in the UK)
30:04 The latest coronavirus research papers
Noah Baker takes a look through some of the key coronavirus papers of the last few weeks.
News: Coronavirus research updates
medRxiv: Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharangel swabs
Nature: Effect of non-pharmaceutical interventions to contain COVID-19 in China
Science: Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China
New England Journal of Medicine:
Podcasts: “Developing Covid-19 Vaccines At Pandemic Speed” (NEJM)
Interview with Dr. Nicole Lurie on rapid vaccine development, including new tools to facilitate vaccine testing and manufacturing and persistent challenges.
The need to rapidly develop a vaccine against SARS-CoV-2 comes at a time of explosion in basic scientific understanding, including in areas such as genomics and structural biology, that is supporting a new era in vaccine development. Over the past decade, the scientific community and the vaccine industry have been asked to respond urgently to epidemics of H1N1 influenza, Ebola, Zika, and now SARS-CoV-2. An H1N1 influenza vaccine was developed relatively rapidly, largely because influenza-vaccine technology was well developed and key regulators had previously decided that vaccines made using egg- and cell-based platforms could be licensed under the rules used for a strain change. Although a monovalent H1N1 vaccine was not available before the pandemic peaked in the Northern Hemisphere, it was available soon afterward as a stand-alone vaccine and was ultimately incorporated into commercially available seasonal influenza vaccines.
Nicole Lurie is a strategic advisor to the CEO of the Coalition for Epidemic Preparedness Innovations. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.
TOP JOURNALS: RESEARCH HIGHLIGHTS FROM SCIENCE MAGAZINE (MAY 8, 2020)
Top New Science Podcasts: ‘Sniff-Response’, Carbon Dioxide And Vaccinations Replacing Antibiotics
This week, how the ‘sniff-response’ can help clinicians determine a patient’s state of consciousness, and how vaccines could help drive down antibiotic use.
In this episode:
00:45 Sniffing out consciousness
Researchers have found that the sniff reflex can indicate whether a patient is in a vegetative state, and even the likelihood that they will recover consciousness. Research Article: Arzi et al.
08:37 Research Highlights
The stupefying effect of carbon dioxide, and a chameleon gemstone that tricks your eyes. Research Highlight: Rising carbon dioxide levels will make us stupider; Research Highlight: How a chameleon gemstone changes from red to green
11:12 Vaccination and antibiotic usage
Looking at data from low- and middle-income countries, researchers have determined that vaccination could prevent millions of infections currently treated by antibiotics. Research Article: Lewnard et al.
16:49 Pick of the Briefing
We pick our highlights from the Nature Briefing, including the forgotten mother of climate change science, and a new global study on insect declines. Chemistry World: Eunice Foote: the mother of climate change; Science: Meta-analysis reveals declines in terrestrial but increases in freshwater insect abundances